Naloxone Hydrochloride
Product Images NDC 63629-9321

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Naloxone Hydrochloride (NDC 63629-9321). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (a) (2y2 Figure 1 (a))

A line graph showing Naloxone plasma concentration (ng/mL) over hours postdose (0 to 6 hours). It compares different dosing regimens including 2 mg and 4 mg sprays in one or both nostrils at 20 mg/mL and 40 mg/mL concentrations, as well as a 0.4 mg intramuscular injection. The graph includes error bars for each data point.*

FDA Label Image

Figure 1 (b) (2y2 Figure 1 (b))

A line chart showing naloxone plasma concentration (ng/mL) over time (hours postdose) for different naloxone hydrochloride dosage forms and amounts, including nasal sprays with 2 mg, 4 mg, and 8 mg doses and a 0.4 mg intramuscular injection. The chart illustrates plasma concentration trends within the first hour after dosing.*

FDA Label Image

Step 3 (2y2 Step 3)

An instructional illustration showing a hand holding a nasal spray device labeled with the components 'Nozzle' at the top and 'Plunger' at the bottom. The image highlights parts of the naloxone hydrochloride nasal spray delivery system.*

FDA Label Image

Step 4 (2y2 Step 4)

An instructional illustration showing a person receiving a nasal spray, with one hand tilting the person's head back and the other hand administering the spray into the nostril. The person is lying down with eyes closed, demonstrating use of a nasal spray device.*

FDA Label Image

Step 5 (2y2 Step 5)

An instructional line drawing showing hands administering a nasal spray into a nostril. The illustration depicts the correct positioning and use of the spray device for nasal delivery.*

FDA Label Image

Step 7 (2y2 Step 7)

An instructional illustration showing a person lying on their side in a recovery position. Labels indicate that one hand supports the head, while the knee stops the body from rolling onto the stomach.*

FDA Label Image

Chemical Structure (Chemical Structure)

Chemical structure diagram of Naloxone Hydrochloride showing the molecular arrangement of atoms including rings, hydroxyl groups, and the hydrochloride component, as commonly depicted in pharmaceutical structural formulas.*

FDA Label Image

Step 2 (Image 01)

An instructional illustration showing a person peeling back the foil cover of a prefilled vial or ampule, likely depicting the removal of packaging for a medication.*

FDA Label Image

Step1-image1 (Image 02)

An instructional illustration showing hands removing the inner packaging from a NALOXONE HYDROCHLORIDE Nasal Spray 4 mg device. The image appears to guide the user on how to properly take the nasal spray out of its sealed pouch before use.*

FDA Label Image

Label (Lbl636299321)

Label for Naloxone HCl Nasal Spray 4 mg by Bryant Ranch Prepack, NDC 63629-9321-01. The label indicates a two-pack of single-dose nasal spray units. It includes storage instructions, dosage form as nasal spray, and usage precautions.*

FDA Label Image

Step 1 (Quick Start Guide Step 1)

Illustration depicting a person kneeling beside another person lying on the ground, demonstrating a first aid or emergency intervention technique, possibly related to administering naloxone hydrochloride.*

FDA Label Image

Step 2 Image 2 (Quick Start Guide Step 2 Image 2)

An instructional diagram illustrating the use of a nasal spray device. The first panel shows a hand holding the device with labels pointing to the nozzle and plunger. The second panel depicts a person lying down while another inserts the nozzle into their nostril. The third panel shows the plunger being pressed to release the spray.*

FDA Label Image

Step 3 (Quick Start Guide Step 3)

An instructional illustration showing a person lying in the recovery position, with annotations indicating the hand supporting the head and the knee preventing the body from rolling onto the stomach.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.